Playlist

International Academic Olympiads to Be Held at Universities of Turkmenistan

24 Jan. 08:57

Source

International-level academic Olympiads are set to take place at higher education institutions across Turkmenistan. This was reported by Deputy Chairperson of the Cabinet of Ministers B. Orazdurdyyeva during a regular digital meeting of the Government of Turkmenistan.

According to information broadcast by the “Watan” news program, several major international competitions are scheduled for March this year in Turkmenistan. The Turkmen State Institute of Architecture and Construction will host the 5th Open International Online Olympiad in Strength of Materials. The International University for the Humanities and Development of Turkmenistan will organize the 6th Open International Mathematics Olympiad, while the State Energy Institute of Turkmenistan will conduct the 5th Open International Online Olympiad in Theoretical Mechanics.

These Olympiads are expected to bring together scholars, professors, and students from higher education institutions of Turkmenistan, alongside participants from leading universities around the world. In this regard, the Deputy Prime Minister submitted relevant proposals for consideration by the President of Turkmenistan.

After reviewing the report, the President of Turkmenistan noted that educational reforms are being successfully implemented nationwide, with strong emphasis placed on identifying talented youth and strengthening international academic cooperation of Turkmenistan. The Head of State approved the proposal to hold international Olympiads at universities of Turkmenistan and instructed officials to carry out the required organizational work.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌